NewsRx

Search our medical news database

Cell Bio-Systems, Inc.

Device firm approves design enhancement for 60cc syringe hub adaptor

Published in Medical Patent Business Week, July 2nd, 2004

Cell Bio-Systems, Inc., (CBSI), a biotechnology company seeking to manufacture and distribute patented, disposable technologies for cosmetic surgery and other living tissue procedures, announced that it has completed a design enhancement for its 60cc syringe hub adaptor.

The 60cc hub adapter is the patented connection system that seals larger diameter cannulas, mostly used to extract fat tissue for re-injection, to a 60cc syringe.

The design enhancement to this patented, disposable device consists of an over-mold, a rubber-like piece molded to the main hub to compensate for variations in syringe diameters. The over-mold will eliminate problems...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook